Rossari Biotech Limited has informed the Exchange regarding 'Business Responsibility & Sustainability Report'.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has filed its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25, as required under SEBI's Listing Regulations. The company operates in specialty chemicals (textile, home & personal care, animal health & nutrition) with FY25 turnover of ₹14,316.28 million and net worth of ₹10,771.74 million. It has a global footprint spanning 26 countries, with exports contributing about 27% of revenue, and a workforce of 531 permanent employees plus 737 contract workers. During the year, the company expanded its subsidiary network by incorporating Rossari Global DMCC, Rossari International Limited, Rossari Biotech Trading FZE, and acquiring Unistar Thai Co. Limited. The report covers all 9 NGRBC principles and identifies material ESG topics including energy/GHG management, water stewardship, waste management, sustainable chemistry, occupational health & safety, and supply chain sustainability. No regulatory fines, anti-corruption cases, or conflict-of-interest complaints were reported, though the BRSR was not externally assured.
This is a routine annual compliance filing and is unlikely to move the stock price on its own. However, retail investors should note the absence of third-party assurance on ESG data and watch for the company's ability to turn stated sustainability commitments into measurable targets in coming years. The expansion into multiple new overseas subsidiaries signals continued global growth ambitions.